Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Bratislava S.E. Other stock markets 06/07/2026			5-day change	1st Jan Change
31.00 ^EUR	0.00%		0.00%	+3.33%

16/03	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
23/02	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	24Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 35Cr 237.45Cr 93Cr 1.15TCr 91Cr 89Cr 3.98TCr	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	24Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 35Cr 236.69Cr 92Cr 1.14TCr 91Cr 89Cr 3.97TCr	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

16/03	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
23/02	Zentiva as responds to EU court decision on UWWTD	RE
12/25/12	Deals of the Day-Mergers and acquisitions	RE
11/25/11	Deals of the Day-Mergers and acquisitions	RE
11/25/11	Zentiva announces sale from Advent to GTCR	RE
11/25/11	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
11/25/11	Deals of the Day-Mergers and acquisitions	RE
11/25/11	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
11/25/11	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
11/25/11	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
20/25/20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
20/25/20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
21/13/21	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

3 months	+3.33%
6 months	+3.33%
Current year	+3.33%

Zentiva, Share Price

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news : Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Course Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

1 month	31	31
Current year	29	33
1 year	29	45
3 years	24	45
5 years	11	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	12/11/2015
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	18/08/2022

Director	Title	Age	Since
Kenneth Lynard BRD	Director/Board Member	58	15/11/2020
Mojmír Krutý BRD	Director/Board Member	-	08/07/2013
Martin Albert BRD	Director/Board Member	-	18/10/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	0.00%	0.00%	+3.33%	+3.33%	5.73Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.57%	+0.13%	+16.45%	+78.10%	4.83TCr
OTSUKA HOLDINGS CO., LTD.	-0.50%	-0.41%	+67.13%	+107.90%	3.53TCr
CIPLA LIMITED	-1.56%	-3.13%	-4.88%	+32.80%	1.18TCr
ZYDUS LIFESCIENCES LIMITED	-1.11%	-3.73%	+16.41%	+81.64%	1.16TCr
KRKA, D. D.	-0.84%	-0.19%	+36.48%	+136.73%	899.08Cr
ONO PHARMACEUTICAL CO., LTD.	-0.27%	+0.42%	+51.66%	-6.22%	692.87Cr
GEDEON RICHTER	-0.77%	-3.48%	+13.66%	+30.68%	672.41Cr
GLENMARK PHARMACEUTICALS LIMITED	+0.24%	-4.02%	+2.19%	+192.78%	643.36Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+1.60%	-9.55%	-30.77%	+8.47%	566.47Cr
Average	-0.25%	-1.56%	+17.17%	+66.62%	1.42TCr
Weighted average by Cap.	-0.17%	-0.93%	+27.60%	+81.77%

	2017	2018
Net sales	14Cr 13Cr 12Cr 11Cr 20Cr 1.38TCr 20Cr 139.4Cr 54Cr 673.95Cr 54Cr 52Cr 2.34TCr	3.62Cr 3.18Cr 2.96Cr 2.72Cr 5.1Cr 350.32Cr 5.19Cr 35Cr 14Cr 170.87Cr 14Cr 13Cr 592.79Cr
Net income	7.8Cr 6.86Cr 6.37Cr 5.86Cr 11Cr 755.13Cr 11Cr 76Cr 30Cr 368.32Cr 29Cr 29Cr 1.28TCr	22.9L 20.14L 18.71L 17.21L 32.27L 22Cr 32.85L 2.24Cr 87.27L 11Cr 85.97L 84.11L 38Cr
Net Debt	-0.09 -0.08 -0.08 -0.07 -0.13 -8.91 -0.13 -0.9 -0.35 -4.35 -0.35 -0.34 -15.08	-0.77 -0.68 -0.63 -0.58 -1.09 -74.96 -1.11 -7.56 -2.95 -36.56 -2.91 -2.84 -126.84